Brazilian Health Regulatory Agency (Anvisa) has approved a new regulation establishing the National Prescription Control System (SNCR) to enhance the management and numbering of prescriptions for controlled medications in Brazil. This measure aims to improve the tracking and security of these prescriptions, reducing fraud and ensuring better control.
How the System Works
The SNCR will provide an online platform for health authorities to issue prescription numbers from a centralized national database. This system ensures that prescriptions are valid across the entire country, following the standards set by Law 13.732/2018.
Health authorities will continue to manage and issue these numbers but will now have the support of an automated online tool. This tool will help track the origin of all prescription notifications, increasing security for pharmacists and minimizing the risk of fraudulent prescriptions.
Implementation Timeline
The SNCR, developed with input from various health authorities and public consultations, will be available for use later in 2024. By January 1, 2025, it will become mandatory for all health authorities in Brazil. Anvisa will conduct training and provide resources to ensure a smooth transition.
Printed prescription pads without SNCR numbers will be valid until January 2027, allowing a gradual shift to the new system.
Importance of the System
The regulation aims to bolster the control of substances under special regulation, such as narcotics and psychotropics. Proper tracking and management are crucial due to the high potential for abuse and illegal diversion of these substances. The National Prescription Control System will support this by ensuring prescribers are registered and prescriptions are traceable.
Conclusion
The implementation of the National Prescription Control System marks a significant step forward in managing controlled medications in Brazil. It promises enhanced security, better tracking, and reduced fraud in prescription management, ultimately protecting public health.
For more detailed information, visit Anvisa’s official website.